Monosodium glutamate


Curated chemical-disease associations from CTD
Disease IDDisease nameReference
MESH:D001068 Feeding and Eating Disorders PMID:25473020
MESH:D001284 Atrophy PMID:12077204
MESH:D001930 Brain Injuries PMID:22447225
MESH:D003072 Cognition Disorders PMID:22447225; PMID:31981724
MESH:D003921 Diabetes Mellitus, Experimental PMID:21549692; PMID:22223845; PMID:28708105
MESH:D005234 Fatty Liver PMID:19001666; PMID:19724016; PMID:21549692; PMID:22144172; PMID:32103741
MESH:D005911 Gliosis PMID:20928830
MESH:D006029 Glycosuria PMID:21549692
MESH:D006130 Growth Disorders PMID:7533119; PMID:8496838; PMID:9053782
MESH:D006529 Hepatomegaly PMID:19001666; PMID:19724016; PMID:21549692; PMID:32103741
MESH:D006937 Hypercholesterolemia PMID:22223845
MESH:D006943 Hyperglycemia PMID:20376352; PMID:21205225; PMID:21549692; PMID:21999347; PMID:22223845; PMID:22415589; PMID:23783067; PMID:28708105; PMID:29679905; PMID:32103741
MESH:D006946 Hyperinsulinism PMID:21205225; PMID:21549692; PMID:22223845; PMID:22415589; PMID:25473020; PMID:25834641
MESH:D006949 Hyperlipidemias PMID:21549692; PMID:22415589
MESH:D006973 Hypertension PMID:25211138
MESH:D007006 Hypogonadism PMID:14657608
MESH:D007249 Inflammation PMID:34560825
MESH:D007333 Insulin Resistance PMID:18048028; PMID:19724016; PMID:19800637; PMID:20111022; PMID:20376352; PMID:21999347; PMID:22144172; PMID:22415589; PMID:23783067; PMID:25834641; PMID:26092479; PMID:28708105; PMID:29679905; PMID:31077719
MESH:D008107 Liver Diseases PMID:34560825
MESH:D009410 Nerve Degeneration PMID:12077204; PMID:30837834; PMID:36732937
MESH:D009765 Obesity PMID:11753755; PMID:12177191; PMID:18930730; PMID:19001666; PMID:19093718; PMID:19724016; PMID:19800637; PMID:20376352; PMID:21205225; PMID:21549692; PMID:21999347; PMID:22223845; PMID:22415589; PMID:2307116; PMID:24502529; PMID:25211138; PMID:25473020; PMID:25497710; PMID:25663641; PMID:25697375; PMID:25834641; PMID:26092479; PMID:26319613; PMID:2734615; PMID:27918843; PMID:2798420; PMID:28708105; PMID:29441869; PMID:29679905; PMID:31077719; PMID:32103741; PMID:3299706; PMID:7533119; PMID:7961801; PMID:8496838; PMID:9717772; PMID:9794456
MESH:D011225 Pre-Eclampsia PMID:22169520
MESH:D011297 Prenatal Exposure Delayed Effects PMID:25697375
MESH:D012640 Seizures PMID:16584647
MESH:D015228 Hypertriglyceridemia PMID:26092479
MESH:D015430 Weight Gain PMID:15231871; PMID:19724016; PMID:20376352; PMID:21205225; PMID:22078008; PMID:22223845; PMID:22415589; PMID:25211138; PMID:25473020; PMID:26900785; PMID:29328403; PMID:34560825
MESH:D015431 Weight Loss PMID:19001666; PMID:7711889
MESH:D018149 Glucose Intolerance PMID:18048028; PMID:20376352; PMID:21205225; PMID:21549692; PMID:29679905
MESH:D020221 Optic Nerve Injuries PMID:12077204
MESH:D024821 Metabolic Syndrome PMID:21549692; PMID:21999347
MESH:D050171 Dyslipidemias PMID:34560825
MESH:D056486 Chemical and Drug Induced Liver Injury PMID:19001666; PMID:19724016; PMID:25211138; PMID:32103741
MESH:D065626 Non-alcoholic Fatty Liver Disease PMID:21549692
MESH:D066126 Cardiotoxicity PMID:34560825

DISCLAIMER

We have built a comprehensive resource which compiles potential endocrine disrupting chemicals (EDCs) based on the observed adverse effects or endocrine-mediated endpoints in published experiments on humans or rodents to support basic research. We are not responsible for any errors or omissions in the published research articles or supporting literature on potential EDCs compiled in this resource. Users are advised to exercise their own judgement on the weight of evidence for potential EDCs compiled in this resource. Importantly, our sole goal to build this resource on potential EDCs is to enable future basic research towards better understanding of the systems-level perturbations upon chemical exposure rather than influencing regulatory advice on chemical use.